Human cholangiocarcinoma development is associated with dysregulation of opioidergic modulation of cholangiocyte growth

Our data indicate that cholangiocarcinoma growth is associated with altered opioidergic regulation of cholangiocyte biology, thus opening new scenarios for future surveillance or early diagnostic strategies for cholangiocarcinoma.